Hepatic encephalopathy: Molecular mechanisms underlying the clinical syndrome

Journal of the Neurological Sciences

Volumn 170, Issue 2, 1999, Pages 138-146

  Albrecht, Jan ^a   Jones, E Anthony ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Ammonia; Benzodiazepines; Catecholamines; Glutamate; Hepatic encephalopathy; Aminobutyric acid

Indexed keywords

AMINO ACID RECEPTOR;

HEPATIC ENCEPHALOPATHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYNAPTIC TRANSMISSION; SYNDROME;

HEPATIC ENCEPHALOPATHY; RECEPTORS, AMINO ACID; SYNAPTIC TRANSMISSION; SYNDROME;

EID: 0033619660     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00169-0     Document Type: Review

References (92)

1. Zieve L. Pathogenesis of hepatic encephalopathy. Metab Brain Dis 1987;2:147-65.
2. Albrecht J. Astrocytes and ammonia neurotoxicity. In: Aschner M, Kimelberg HK, editors, The role of glia in neurotoxicity, Boca Raton, FL: CRC Press, 1996, pp. 137-53.
3. Albrecht J, Faff L. Astrocyte-neuron interactions in hyperammonemia and hepatic encephalopathy. Adv Exp Biol Med 1994;368:45-54.
4. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979;161:303-10.
5. Adams RD, Foley JM. The neuroglial disorder associated with liver disease. Res Publ Assoc Res Nerv Ment Dis 1953;32:198-237.
6. Jones EA, Weissenborn K. Neurology and the liver. J Neurol Neurosurg Psychiatry 1997;63:279-93.
7. 3H]D-aspartate from hippocampal slices distinguishes encephalopathy related to acute liver failure from that induced by simple hyperammonemia. Brain Res 1991;567:165-8.
8. Moroni F, Lombardi G, Moneti G, Cortesini C. The release and the neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem 1983;40:850-4.
9. Michalak A, Rose C, Butterworth J, Butterworth RF. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology 1996;24:908-13.
10. Oja SS, Saransaari P, Wysmyk U, Albrecht J. Loss of GABAB binding sites in the cerebral cortex of rats with acute hepatic encephalopathy. Brain Res 1993;629:355-7.
11. Vogels BA, Maas MA, Daalhuisen J, Quack G, Chamuleau RA. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 1997;25(4):820-7.
12. Saran T, Hilgier W, Kocki T, Urbańska EM, Turski W, Albrecht J. Acute ammonia treatment in vitro and in vivo inhibits the synthesis of a neuroprotectant kynurenic acid in rat cerebral cortical slices. Brain Res 1998;787:348-50.
13. +-ATPase activity and GABA uptake in astroglial cell-enriched fractions and synaptosomes derived from rats in the early stage of experimental hepatogenic encephalopathy. Acta Neurol Scand 1985;72:317-20.
14. + -ATPase. J Neurochem 1994;63:2172-8.
15. + -ATPase activities are increased in brain in both congenital and acquired hyperammonemic syndromes. Neurosci Lett 1995;197:89-92.
16. Felipo V, Grau E, Miñana MD, Grisolia S. Hyperammonemia decreases protein-kinase C-dependent phosphorylation of microtubule-associated protein 2 and increases its binding to tubulin. Eur J Biochem 1993;214:243-9.
17. Kosenko E, Kaminsky Y, Grau E, Miñana MD, Grisolia S, Felipo V. Nitroarginine, an inhibitor of nitric oxide synthetase, attenuates ammonia toxicity and ammonia-induced alterations in brain metabolism. Neurochem Res 1995;20(4):451-6.
18. Kosenko E, Kaminsky Y, Kaminsky A, Valencia M, Lee L, Hermenegildo C, Felipo V Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic Res 1997;27:637-44.
19. Kosenko E, Kaminsky Y, Lopata O, Muravyov N, Kaminsky A, Hermenegildo C, Felipo V. Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonium acetate. Metab Brain Dis 1998;13:29-41.
20. Albrecht J, Hilgier W, Rafalowska U. Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide-induced hepatic encephalopathy: an adaptive response. J Neurosci Res 1990;25:125-30.
21. 3H] nitroarginine into rat brain synaptosomes. J Neurochem 1997;68:337-43.
22. 3H] arginine uptake in brain following portacaval anastomosis. J Neurochem 1995;65:677-81.
23. Saransaari P, Oja SS, Borkowska HD, Kostinaho J, Hilgier W, Albrecht J. Effects of thioacetamide-induced hepatic failure on the N-methyl-D-aspartate receptor complex in the rat cerebral cortex, striatum and hippocampus: binding of different ligands and expression of receptor subunit mRNA's. Mol Chem Neuropathol 1997;32:179-94.
24. Peterson C, Giguere J-F, Cotman CW, Butterworth RF. Selective loss of N-methyl-D-aspartate binding sites in rat brain following portacaval anastomosis. J Neurochem 1990;55:386-90.
25. 3H] MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency. Metab Brain Dis 1995;10:249-55.
26. 3H]amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding in a spontaneous canine model of chronic hepatic encephalopathy. J Neurochem 1991;56:1881-8.
27. 3H]5-fluorowillardiine in the brains of rats with acute liver failure. Hepatology 1997;25:631-5.
28. Hermenegildo C, Montoliu C, Llansola M, Muñoz MD, Gaztelu JM, Minana MD, Felipo V. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur J Neurosci 1998;10:3201-9.
29. Miñana MD, Marcaida G, Grisolia S, Felipo V. Prenatal exposure of rats to ammonia impairs NMDA receptor function and affords delayed protection against ammonia toxicity and glutamate neurotoxicity. J Neuropathol Exp Neurol 1995;54:644-50.
30. Marcaida G, Miñana MD, Burgal M, Grisolia S, Felipo V. Ammonia prevents activation of NMDA receptors by glutamate in rat cerebellar neuronal cultures. Eur J Neurosci 1995;7:2389-96.
31. Tossman J, Delin A, Eriksson LS, Ungerstedt U. Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats. Neurochem Res 1987;12:265-9.
32. Hilgier W, Zielinska M, Borkowska HD, Gadamski R, Walski M, Oja SS, Saransaari P, Albrecht J. Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure. J Neurosci Res 1999;56:76-84.
33. Albrecht J, Hilgier W, Lazarewicz JW, Rafalowska U, Wysmyk-Cybula U. Astrocytes in acute hepatic encephalopathy: metabolic properties and transport functions. In: Norenberg MD, Hertz L, Schousboe A, editors, Biochemical pathology of astrocytes, New York: R. Liss, 1988, pp. 465-76.
34. Knecht K, Michalak A, Rose C, Rothstein JD, Butterworth RF. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci Lett 1997;229:201-3.
35. Norenberg MD, Hugo Z, Neary JT, Roig-Cantesano A. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission. Glia 1997;21:124-33.
36. Oppong KNW, Bartlett K, Record CO, Mardini HA. Synaptosomal glutamate transport in thioacetamide-induced hepatic encephalopathy in the rat. Hepatology 1995;22:553-8.
37. Fan P, Lavoie J, Le NLO, Szerb JC, Butterworth RF. Neurochemical and electro-physiological studies on the inhibitory effect of ammonium ions on synaptic transmission in slices of rat hippocampus: evidence for a postsynaptic action. Neuroscience 1990;37(2):327-34.
38. Lombardi G, Mannaioni G, Leonardi P, Cherici G, Carla V, Moroni F. Ammonium acetate inhibits ionotropic receptors and differentially affects metabotropic receptors for glutamate. J Neural Transm [GenSect] 1994;97:187-96.
39. Westergaard N, Sonnewald U, Schousboe A. Metabolic trafficking between neurons and astrocytes: the glutamate/glutamine cycle revisited. Dev Neurosci 1995;17:203-11.
40. 13C-NMR studies. J Neurochem 1996;4:1711-7.
41. Bansky G, Meier PJ, Ziegler WH, Walser H, Schmid M, Huber M. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1985;1:1324-5.
42. Scollo-Lavizzari G, Steinmann E. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1985;1:1324.
43. Ferenci P, Herneth A, Steindl P. Newer approaches to therapy of hepatic encephalopathy. Semin Liver Dis 1996;16:329-38.
44. Bassett ML, Mullen KD, Skolnick P, Jones EA. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology 1987;93:1069-77.
45. Gammal SH, Basile AS, Geller D, Skolnick P, Jones EA. Reversal of the behavioural and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology 1990;11:371-8.
46. Ferreira MR, Gammal SH, Jones EA. Resistance to 3-mercaptopropionic acid-induced seizures in hepatic encephalopathy. Hepato-Gastroenterology 1997;44:766-9.
47. Basile AS, Gammal SH, Mullen KD, Jones EA, Skolnick P. Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy. J Neurosci 1988;8:2414-21.
48. Baku G, Fisch HU, Karlaganis G, Minder C, Bircher J. Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam. Hepatology 1987;7:629-38.
49. Basile AS, Hughes RD, Harrison PM, Murata Y, Pannell L, Jones EA, Williams R, Skolnick P. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med 1991;325:473-8.
50. Olasmaa M, Rothstein JD, Guidotti A, Weber RJ, Paul SM, Spector S, Baraldi M, Costa E. Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J Neurochem 1990;55:2015-33.
51. Wysmyk U, Oja SS, Saransaari P, Albrecht J. Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy. Neurochem Res 1992;17:1187-90.
52. Albrecht J, Rafalowska U. Enhanced potassium-stimulated γ-aminobutyric acid release by astrocytes derived from rats with early hepatogenic encephalopathy. J Neurochem 1987;49:9-11.
53. Takahashi K, Kameda H, Kataoka M, Sanjou K, Harata N, Akaike N. Ammonia potentiates GABAA response in dissociated rat cortical neurons. Neurosci Lett 1993;151:51-4.
54. Basile AS, Jones EA. Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 1997;25:1303-5.
55. Ha JH, Basile AS. Modulation of ligand binding to components of the GABAA receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes. Brain Res 1996;720:35-44.
56. Willow M, Johnson GAR. Dual action of pentobarbitone on GABA binding: role of binding site integrity. J Neurochem 1981;37:1291-4.
57. Itzhak Y, Baker L, Norenberg MD. Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity. Glia 1993;9:211-8.
58. Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABA-A receptor: mechanism of action and physiological significance. Prog Neurobiol 1992;38:370-95.
59. Lavoie J, Pomier-Layrargues G, Butterworth RF. Increased densities of 'peripheral-type' benzodiazepine receptors in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology 1990;11:874-8.
60. Desjardin P, Bandeira P, Rao VLR, Ledoux S, Butterworth RF. Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein mRNA in brain following portacaval anastomosis. Brain Res 1997;758:255-8.
61. Itzhak Y, Roig-Cantisano A, Dombro RS, Norenberg MD. Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res 1995;705:345-8.
62. Itzhak Y, Norenberg MD. Attenuation of ammonia toxicity in mice by PK 11195 and pregnenolone sulfate. Neurosci Lett 1994;182:251-4.
63. Bender AS, Norenberg MD. Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes. J Neurosci Res 1998;54:673-80.
64. O'Grady JG, Gimson AES, O'Brien CJ et al. Controlled trial of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-91.
65. Traber P, DalCanto M, Ganger D, Blei AT. Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure. Hepatology 1987;7:1257-61.
66. Ganz R, Swain M, Traber P et al. Ammonia-induced swelling of rat cerebral cortical slices: implications for the pathogenesis of brain edema in acute hepatic failure. Metab Brain Dis 1989;4(3):214-33.
67. Takahashi H, Koehler RC, Brusilow SW, Traystman RJ. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991;261:H825-9.
68. 2 responsivity by glutamine synthesis inhibition in hyperammonemic rats. Circ Res 1992;71:1220-30.
69. Willard-Mack CL, Koehler RC, Hirata T et al. Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in the rat. Neuroscience 1996;71:589-99.
70. Sugimoto H, Koehler RC, Wilson DA et al. Methionine sulfoximine, a glutamine synthetase inhibitor, attenuates increased extracellular potassium activity during acute hyperammonemia. J Cereb Blood Flow Metab 1997;17:44-9.
71. + ATPase activity by serum from patients with fulamint hepatic failure. Hepatology 1984;4:74-9.
72. Therrien G, Butterworth RF. Cerebrospinal fluid amino acids in relation to neurological status in experimental portal-systemic encephalopathy. Metab Brain Dis 1991;6:65-74.
73. Cordoba J, Gottstein J, Blei AT. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 1996;24:919-23.
74. Hilgier W, Olson JE, Albrecht J. Relation of taurine transport and brain edema in rats with simple hyperammonemia or liver failure. J Neurosci Res 1996;45:69-74.
75. Zielińska M, Hilgier W, Law RO, Goryński P, Albrecht J. Effects of ammonia in vitro on endogenous taurine efflux and cell volume in rat cerebrocortical minislices: influence of inhibitors of volume-sensitive amino acid transport. Neuroscience 1999;91:631-8.
76. Hilgier W, Puka M, Albrecht J. Characteristics of large neutral amino acid-induced release of preloaded glutamine from rat cerebral capillaries in vitro: effects of ammonia, hepatic encephalopathy and γ-glutamyltranspeptidase inhibitors. J Neurosci Res 1992;32:221-6.
77. +-independent systems. J Biol Chem 1983;258:8949-54.
78. Kanamori K, Ross BD, Chung JC, Kuo El. Severity of hyperammonemic encephalopathy correlates with brain ammonia level and saturation of glutamine synthetase in vivo. J Neurochem 1996;67:1584-94.
79. Mullen KD, Gacad R, Kaminsky-Russ K. Reducing brain glutamine synthesis does not improve behavior in portacaval shunted rats. In: Record C, Al-Mardini H, editors, ISA 96, Newcastle-upon-Tyne, Advances in hepatic encephalopathy and metabolism in liver disease, 1996, pp. 423-6.
80. Mousseau DD, Baker GB, Butterworth RF. Increased density of catalytic sites and expression of brain monoamine oxidase a in humans with hepatic encephalopathy. J Neurochem 1997;68:1200-8.
81. Bergqvist PBH, Hjorth S, Audet R, Apelquist G, Bengtsson F, Butterworth RF. Ammonium acetate challenge in experimental hepatic encephalopathy induces a transient increase of brain HT release in vivo. Eur Psychopharmacol 1996;6:317-22.
82. 2A/2C receptor binding in the frontal cortex of rats with thiocetamide-induced hepatic encephalopathy. J Neural Transm 1998;105:13-30.
83. 3H]ketanserin binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurosci Lett 1994;182:69-72.
84. Robinson MB, Anegawa NJ, Gorry E, Qureshi IA, Coyle JT, Lucki I, Batshaw ML. Brain serotonin 2 and serotonin 1A receptors are altered in the congenitally hyperammonemic sparse fur mouse. J Neurochem 1992;58:1016-22.
85. Yurdaydin C, Herneth AM, Püspök A et al. Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists. Eur J Hepatol Gastroenterol 1996;8:667-71.
86. Carpenedo R, Mannaioni G, Moroni F. Oxindole, a sedative tryptophan metabolite, accumulates in blood and brain of rats with acute hepatic failure. J Neurochem 1998;70:1998-2003.
87. Moroni F, Carpenedo R, Venturini I, Baraldi M, Zeneroli ML. Oxindole in pathogenesis of hepatic encephalopathy. Lancet 1998;351:1861.
88. 2 receptor density in hepatic encephalopathy. Neurosci Lett 1993;162:192-6.
89. B in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Res 1993;621:349-52.
90. Wheeler D, Boutelle MG, Fillenz M. The role of N-methyl-D-aspartate receptors in the regulation of physiologically released dopamine. Neuroscience 1995;65:767-74.
91. Borkowska H, Oja SS, Saransaari P, Hilgier W, Albrecht J. N-Methyl-D-aspartate-evoked changes in the striatal extracellular levels of dopamine and its metabolites in vivo in rats with acute hepatic encephalopathy. Neurosci Lett 1999;268:151-4.
92. 3H] dopamine from striatal and cerebral cortical slices from rats with thioacetamide-induced hepatic encephalopathy: different responses to stimulation by potassium ions and agonists of ionotropic glutamate receptors. Neurochem Res 1997;22:101-6.